Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Matityahu, Fridkin"'
Autor:
Rona Limor, Yoram Shechter, Keren Sasson, Fortune Kohen, Matityahu Fridkin, Dafna Benayahu, Naftali Stern, Nava Nevo, Orit Pappo, Gabi Shefer, Michal Yacobi Bach, Inbal E. Biton, Tamara Berkutzki, Yonit Marcus
Publikováno v:
Diabetes. 62:1121-1130
We studied the effects of chronic angiotensin 1-7 (Ang 1-7) treatment in an experimental model of the metabolic syndrome, i.e., rats given high-fructose/low-magnesium diet (HFrD). Rats were fed on HFrD for 24 weeks with and without Ang 1-7 (576 µg/k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b715adca01e2e56b4b10307bde1d6963
https://doi.org/10.2337/db12-0792
https://doi.org/10.2337/db12-0792
Publikováno v:
ACS Chemical Neuroscience. 1:399-406
Many peptides with the potential of therapeutic action for brain disorders are not in clinical use because they are unable to cross the blood-brain barrier (BBB) following peripheral administration. We have developed two potential strategies for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95c0ccfe77a9d3df62ddcd8a2d4a0161
https://doi.org/10.1021/cn100001j
https://doi.org/10.1021/cn100001j
Autor:
Vered Daniel-Carmi, In-Sook Ahn, Matityahu Fridkin, M-S Do, G Lugassy, Ezra Vadai, Lior Carmon, Adrian Paz, Lea Eisenbach, Erez Bar-Haim, Arthur Machlenkin, Esther Tzehoval, Boaz Tirosh
Publikováno v:
British Journal of Cancer
D(b-/-)xbeta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/D(b)-beta2m single chain (HHD mice) are an effective biological tool to evaluate the antitumour cytotoxic T-lymphocyte response of known major histocompatibility-restri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0f5a8ed9a090915e48ed050dd35f87
https://doi.org/10.1038/sj.bjc.6604061
https://doi.org/10.1038/sj.bjc.6604061
Autor:
Illana Gozes, A. Reshef, Ariane Davidson, R. Glazer, Matityahu Fridkin, Terry W. Moody, Rachel Zamostiano, Amos Bardea, A. Ticher, S. Rubinraut, Osnat Ashur-Fabian, G. Lilling, Douglas E. Brenneman, I. E. Ashkenazi
Publikováno v:
Annals of the New York Academy of Sciences. 805:159-169
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ea196558f5d9268f9d2664f2d52b21
https://doi.org/10.1111/j.1749-6632.1996.tb17481.x
https://doi.org/10.1111/j.1749-6632.1996.tb17481.x
Publikováno v:
Pure and Applied Chemistry. 77:1617-1628
We report that oral administration of vanadium (+5) combined with L-glutamic acid γ-monohydroxamate at 1:2 stoichiometry [L-Glu(γ)HXM.VO3 -] is highly effective in reducing blood glucose levels (BGLs) in a wide variety of diabetic rodents. In strep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27b98902878c48125da5b7f0d9a8ce47
https://doi.org/10.1351/pac200577091617
https://doi.org/10.1351/pac200577091617
Autor:
Meirav Trebicz-Geffen, Dror Robinson, Zoharia Evron, Tova Glaser, Matityahu Fridkin, Yehuda Kollander, Israel Vlodavsky, Neta Ilan, Kit Fong Law, Kathryn S. E. Cheah, Danny Chan, Haim Werner, Zvi Nevo
Publikováno v:
International Journal of Experimental Pathology. 90:191-193
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb7ddcdb97b018933474bc904c8b57f
https://doi.org/10.1111/j.1365-2613.2009.00655.x
https://doi.org/10.1111/j.1365-2613.2009.00655.x
Autor:
Sonia B. Jakowlew, F. Jameison, T. Coelho, K. Takahashi, M. Knight, Terry W. Moody, M. Koh, Julius Leyton, Matityahu Fridkin, Illana Gozes
Publikováno v:
Life Sciences. 61:1657-1666
The effects of VIP receptor antagonists were investigated using non-small cell lung cancer (NSCLC) cells. By Northern blot and RT-PCR, VIP1 receptors were detected on NSCLC cell line NCI-H1299. VIPhybrid,(N-Stearyl-Norleucine17) VIPhybrid ((SN) VIPhy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec37c25a99a4e830df8eb0cfb5091ca
https://doi.org/10.1016/s0024-3205(97)00771-6
https://doi.org/10.1016/s0024-3205(97)00771-6
Autor:
Yonit, Marcus, Gabi, Shefer, Keren, Sasson, Fortune, Kohen, Rona, Limor, Orit, Pappo, Nava, Nevo, Inbal, Biton, Michal, Bach, Tamara, Berkutzki, Matityahu, Fridkin, Dafna, Benayahu, Yoram, Shechter, Naftali, Stern
Publikováno v:
Diabetes
We studied the effects of chronic angiotensin 1-7 (Ang 1-7) treatment in an experimental model of the metabolic syndrome, i.e., rats given high-fructose/low-magnesium diet (HFrD). Rats were fed on HFrD for 24 weeks with and without Ang 1-7 (576 µg/k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5190db38507ab42cecb2e2f657adc39
https://pubmed.ncbi.nlm.nih.gov/23250359
https://pubmed.ncbi.nlm.nih.gov/23250359
Publikováno v:
Neuropeptides. 40:423-424
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9612a8814e78a085012e2cf20dcf846
https://doi.org/10.1016/j.npep.2006.09.005
https://doi.org/10.1016/j.npep.2006.09.005
Autor:
Karin Golan, David T. Scadden, Borja Saez, Aviva Lapidot, Ehrahrdt Proksch, Matityahu Fridkin, Tomer Itkin, Kerstin Ahrens, Tsvee Lapidot, Shiri Gur-Cohen, Alexander Kalinkovich, Amir Schajnovitz, Orit Kollet, Aya Ludin, Kfir Lapid, Alexander Berchanski
Publikováno v:
Blood. 122:890-890
Background Rapid mobilization of hematopoietic stem and progenitor cells (HSPCs) from the bone marrow (BM) to the peripheral blood by anti-CXCR4 agents such as AMD3100 is a complex process, which requires CXCL12 secretion, activation of proteolytic e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a285c78c832420aa0218a3636af1db06
https://doi.org/10.1182/blood.v122.21.890.890
https://doi.org/10.1182/blood.v122.21.890.890